XML 40 R27.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Assumptions Used to Compute Share-Based Compensation Costs for Stock Options Granted

The assumptions used to compute the share-based compensation costs for the stock options granted during the years ended December 31, 2015, 2014, and 2013, respectively, using the Black-Scholes option pricing model, were as follows:

 

     Year Ended December 31,  
     2015     2014     2013  

Weighted average grant-date fair value of stock options

   $ 0.77      $ 0.57      $ 0.63   

Assumptions

      

Risk-free interest rate (weighted average)

     1.1     1.2     0.6

Expected dividend yield

     —          —          —     

Weighted average expected life (years)

     4        4        4   

Volatility (weighted average)

     83.5     82.9     68.1

Forfeiture rate

     23.3     25.5     11.4
Assumptions Used Estimate Fair Value of Employee Stock Purchase Plans

Following is a schedule of the shares purchased, the fair value per share, and the Black-Scholes model assumptions for each offering period:

 

     (Ending)                          
Offering Period Ended    September 30,     March 31,     September 30,     March 31,     September 30,  
     2015     2015     2014     2014     2013  

Shares purchased for offering period

     12,451        11,216        13,619        13,734        19,490   

Fair value per share

   $ 0.60      $ 0.43      $ 0.83      $ 0.30      $ 0.44   

Assumptions

          

Risk-free interest rate (average)

     0.11     0.40     0.80     0.40     0.11

Expected dividend yield

     —          —          —          —          —     

Weighted average expected life (years)

     0.5        0.5        0.5        0.5        0.5   

Volatility (average)

     103.8     109.1     74.0     44.0     45.0
Non-Cash Stock-Based Compensation Expenses

Non-cash stock-based compensation expenses related to stock options, restricted stock grants and the ESPP were recorded in the financial statements as follows (in thousands):

 

     Year Ended December 31,  
     2015      2014      2013  

Cost of revenues

   $ 12       $ 13       $ 20   

Selling and marketing

     335         270         766   

Research and development

     644         659         809   

General and administrative

     1,167         1,437         1,938   

Restructuring expense

     —           1,273         —     
  

 

 

    

 

 

    

 

 

 

Total non-cash stock compensation expense

   $ 2,158       $ 3,652       $ 3,533   
  

 

 

    

 

 

    

 

 

 

Summary of Outstanding Stock Options and Related Activity

A summary of the Company’s stock options outstanding under the 2015 Plan as of December 31, 2015 and the activity during the years ended herein are as follows (in thousands except per share amounts):

 

     Shares     Weighted Ave.
Exercise Price
     Aggregate
Intrinsic Value
 

Outstanding as of December 31, 2012

     2,275      $ 7.02       $ —     
  

 

 

   

 

 

    

 

 

 

(1,474 options exercisable at a weighted average exercise price of $10.09)

       

Granted (weighted average fair value of $0.63)

     120      $ 1.31      

Exercised

     —        $ —        

Cancelled

     (225   $ 6.52      
  

 

 

      

 

 

 

Outstanding as of December 31, 2013

     2,170      $ 6.76       $ —     
  

 

 

      

 

 

 

(1,573 options exercisable at a weighted average exercise price of $8.81)

       

Granted (weighted average fair value of $0.57)

     633      $ 0.95      

Exercised

     (4   $ 1.38      

Cancelled

     (665   $ 5.98      
  

 

 

      

 

 

 

Outstanding as of December 31, 2014

     2,134      $ 5.29       $ —     
  

 

 

      

 

 

 

(1,291 options exercisable at a weighted average exercise price of $8.04)

       

Granted (weighted average fair value of $0.77)

     75      $ 1.27      

Exercised

     (8   $ 1.19      

Cancelled

     (556   $ 4.05      
  

 

 

      

 

 

 

Outstanding as of December 31, 2015

     1,645      $ 5.39       $ —     
  

 

 

      

 

 

 

Exercisable as of December 31, 2015

     1,132      $ 7.34       $ —     
  

 

 

      

 

 

 

Vested and expected to vest at December 31, 2015

     1,593      $ 5.53       $ —     
  

 

 

      

 

 

 
Summary of Outstanding Restricted Stock Awards and Related Activity

A summary of the Company’s restricted stock awards outstanding under the 2005 Plan as of December 31, 2015, and the activity during years ended therein, are as follows (in thousands):

 

     Number
of shares
     Weighted average
grant
date fair value
 

Unvested at December 31, 2012

     1,319       $ 4.60   
  

 

 

    

Granted

     1,495       $ 1.70   

Vested

     (752    $ 4.43   

Cancelled and forfeited

     (316    $ 3.00   
  

 

 

    

Unvested at December 31, 2013

     1,746       $ 2.48   
  

 

 

    

Granted

     1,625       $ 1.79   

Vested

     (1,442    $ 2.48   

Cancelled and forfeited

     (204    $ 1.79   
  

 

 

    

Unvested at December 31, 2014

     1,725       $ 1.91   
  

 

 

    

Granted

     1,375       $ 1.50   

Vested

     (1,011    $ 1.95   

Cancelled and forfeited

     (284    $ 1.67   
  

 

 

    

Unvested at December 31, 2015

     1,805       $ 1.61